Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2025 Earnings Call Transcript October 30, 2025
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2.9, expectations were $0.561.
Operator: Good morning, ladies and gentlemen, and welcome to the Alnylam Pharmaceuticals 3Q 2025 Earnings Conference Call. [Operator Instructions] Also note that this call is being recorded on Thursday, October 30, 2025. And I would like to turn the conference over to management. Please go...
